Mateus F. Alves, Marcus T. Scotti, Luciana Scotti*, Francisco Jaime Bezerra Mendonça, José M. B. Filho, Sílvia A. L. de Melo, Sócrates G. dos Santos and Margareth de F.F.M. Diniz Pages 1629 - 1644 ( 16 )
The genus Cissampelos comprises of 21 species which have a wide global distribution and various pharmacological activities such as analgesic and antipyretic, antiinflammatory, anti-allergic, bronchodilation, and immunomodulation among others. Several compounds, mainly alkaloids with differing biological activities have been isolated from this genus. We will highlight antipyretic activities, anti-inflammatory, antiallergic, bronchodilatory, and immunomodulatory activities. In addition, we applied ligand-based-virtual screening associated with structure-based-virtual screening of a small dataset of 63 secondary metabolites from the Cissampelos genus of an in-house data bank, in order to select compounds with potential anti-inflammatory activity. Affinities were observed for hayatine (26), isochondrondendrine (30), pelosine (52), sepeerine (59), and warifteine (63) to the inhibiting enzymes MAPK p38 alpha, PKC beta, PKC theta and PKC zeta. The cissampeloflavone compound (8) alone showed no potential inhibitory activity for PKC zeta, or affinity for the PKC alpha. The compounds can be used as starting points for further studies on structures with potential anti-inflammatory activity.
Cissampelos, anti-inflammatory activity, virtual screening, multi-target, secondary metabolites, asthma.
Postgraduate Program in Natural and Synthetic Bioactive Products, Federal University of Paraíba, João Pessoa – PB, Postgraduate Program in Natural and Synthetic Bioactive Products, Federal University of Paraíba, João Pessoa – PB, Health Sciences Center, Federal University of Paraíba, Campus I, 58051-970, João Pessoa- PB, Laboratory of Synthesis and Drug Delivery, Department of Biological Science, State University of Paraiba, João Pessoa, PB, Postgraduate Program in Natural and Synthetic Bioactive Products, Federal University of Paraíba, João Pessoa – PB, Postgraduate Program in Natural and Synthetic Bioactive Products, Federal University of Paraíba, João Pessoa – PB, Research Institute for Drugs and Medicines, Federal University of Paraíba, João Pessoa – PB, Postgraduate Program in Natural and Synthetic Bioactive Products, Federal University of Paraíba, João Pessoa – PB